Literature DB >> 9342070

Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: evidence from a cohort of 347 HIV-infected individuals.

H Ullum1, A C Lepri, J Victor, P Skinhøj, A N Phillips, B K Pedersen.   

Abstract

OBJECTIVE: To examine changes in the distribution of CD4+CD45RA+ (naive) and CD4+CD45RO+ (memory) lymphocytes in various stages of HIV infection and the effect of these changes on disease progression. DESIGN AND METHODS: Expression of CD45RA+ and CD45RO+ on CD4+ lymphocytes was analysed by flow cytometry in a prospectively followed cohort of 300 HIV-infected individuals (median follow-up time, 2.90 years; range, 0.02-4.54 years) and in a group of 102 age- and sex-matched uninfected controls. Survival analysis was performed considering AIDS development and death as endpoints.
RESULTS: The median CD4+CD45RA+/CD45RO+ ratio was 1.3 (25-75% quartiles, 0.9-2.4) in controls; it was increased to 1.8 (1.1-2.5) in 40 HIV-infected individuals with CD4+ cell counts > 500 x 10(6)/l (P < 0.05); it was similar at 1.4 (0.8-2.0) in 106 HIV-infected individuals with CD4+ cell counts of 200-500 x 10(6)/l; and it was decreased to 0.9 (0.5-1.4) in 154 HIV-infected individuals with CD4+ cell counts < 200 x 10(6)/l (P < 10[-6]). When fitted in a Cox model adjusting for the total number of CD4+ cells and age a lower concentration of CD4+CD45RA+ cells was associated with an increased risk of dying. The concentration of CD4+CD45RO+ cells was not significantly associated with AIDS or death in age- and CD4+ cell count-adjusted Cox models.
CONCLUSIONS: This study confirms a selective loss of memory CD4+ cells early in HIV infection followed by increased loss of naive CD4+ cells in later stages of the infection. The loss of naive CD4+ cells seems to be important in the pathogenesis of terminal HIV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342070     DOI: 10.1097/00002030-199712000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.

Authors:  G R Kaufmann; J Zaunders; D A Cooper
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

3.  CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children.

Authors:  O Nájera; C González; G Toledo; L López; E Cortés; M Betancourt; R Ortiz
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  T cell signaling mechanisms that regulate HIV-1 infection.

Authors:  D Unutmaz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro.

Authors:  Y J Zhang; T Dragic; Y Cao; L Kostrikis; D S Kwon; D R Littman; V N KewalRamani; J P Moore
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.

Authors:  Allan R Tenorio; Hongyu Jiang; Yu Zheng; Barbara Bastow; Daniel R Kuritzkes; John A Bartlett; Steven G Deeks; Alan L Landay; Sharon A Riddler
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

7.  Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx).

Authors:  Richard Onanga; Sandrine Souquière; Maria Makuwa; Augustin Mouinga-Ondeme; François Simon; Cristian Apetrei; Pierre Roques
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.

Authors:  Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

9.  Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission.

Authors:  Erica L Johnson; Chanie L Howard; Joy Thurman; Kyle Pontiff; Elan S Johnson; Rana Chakraborty
Journal:  J Infect Dis       Date:  2014-07-31       Impact factor: 5.226

10.  Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies.

Authors:  Takeo Kuwata; Yoshiaki Nishimura; Sonya Whitted; Ilnour Ourmanov; Charles R Brown; Que Dang; Alicia Buckler-White; Ranjini Iyengar; Jason M Brenchley; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.